Photoprotection of HaCaT cells against UVA radiation by melanin-binding hydroxychloroquine in vitro

Xiao-lan WANG,Wei CHE,Qiong ZHOU,Tie-chi LEI,Hong LIANG,Shi-zheng XU

DOI: https://doi.org/10.3969/j.issn.1000-4963.2008.02.004

2008-01-01

Abstract:Objective: To define the photoprotection of HaCaT cells against UVA radiation and the capacity of scavenging reactive oxygen species (ROS) by melanin-binding hydroxychloroquine (HCQ). Methods: The bacteria-derived melanin (b-melanin), an analog of synthetic eumelanin, was isolated from the cultivation of Pseudomonas maltophila AT18. To mimic the accumulation of HCQ in the epidermal melanin in vivo, the varying concentrations of HCQ were incubated with 50 g/L b-melanin for 3 h to allow their binding sufficiently, and then pre-treated HaCaT cells with melanin-binding HCQ and determined their photoprotection against the lethal dose 50% (30 J/cm 2) of UVA radiation. The viabilities of HaCaT cells were measured by MTT assay after 12 hours of UVA radiation, the apoptosis was detected by flow cytometry with a propidium iodide (PI) staining, and the level of intracellular ROS was monitored by DCFH-DA labeling. Results: Low concentration (10 or 50 μmol/L) of HCQ was bound with 50 mg/L b-melanin, which could afford an enhanced photoprotection of HaCaT cells against UVA radiation (30 J/cm 2). In comparison with b-melanin or HCQ treatment, the survival rate was significantly increased in the HaCaT cells treated with 50 μmol/L HCQ-bound b-melanin (P < 0.05). It was surprising that high concentration (250 μmol/L) of HCQ was bound with b-melanin to demonstrate phototoxicity to some extent on UVA-exposed HaCaT cells. Furthermore, the augmentation of ROS scavenging and the inhibition of UVA-induced apoptosis were also found in HaCaT cells treated with 10 μmol/L HCQ-bound b-melanin. Conclusions: The binding of low dose (10-50 μmol/L) of HCQ with melanin dramatically increases the capacity of ROS scavenging and protects the keratinocytes from UVA-induced apoptosis, which may contribute to anti-photosensitivity of antimalarials in the treatment of cutaneous lupus erythematosus.